REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
15.02
+0.92 (6.52%)
At close: Jan 21, 2026, 4:00 PM EST
15.15
+0.13 (0.87%)
After-hours: Jan 21, 2026, 7:53 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $760.36 million as of January 21, 2026. Its market cap has increased by 95.26% in one year.
Market Cap
760.36M
Enterprise Value
726.46M
1-Year Change
95.26%
Ranking
Category
Stock Price
$15.02
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has increased from $749.30M to $760.36M, an increase of 1.48%. That is a compound annual growth rate of 0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 713.80M | -2.09% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 748.35M |
| MapLight Therapeutics | 741.03M |
| Nektar Therapeutics | 736.98M |
| SELLAS Life Sciences Group | 735.62M |
| Gyre Therapeutics | 720.76M |
| Astria Therapeutics | 710.14M |
| Jade Biosciences | 701.56M |
| Fulcrum Therapeutics | 699.29M |